Gilead’s Remdesivir Becomes First Virus Treatment to Win FDA Nod

(Bloomberg) -- The U.S. Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy remdesivir on Thursday, making it the first drug to obtain formal clearance for treating the c...